Preoperative imaging for hepatic resection of colorectal cancer metastasis

Journal of Gastrointestinal Oncology

Volumn 3, Issue 1, 2012, Pages 11-18

  Frankel, Timothy L ^a   Do, Richard Kinh Gian ^b   Jarnagin, William R ^a  

^a Departments of Medicine and Surgery   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal metastases; Hepatic artery infusion pump; Hepatic resection; Preoperative imaging; Volumetrics

Indexed keywords

ECHOVIST; FLOXURIDINE; FLUORODEOXYGLUCOSE F 18; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM PENTETATE; GADOXETIC ACID; IODINATED CONTRAST MEDIUM;

ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HEPATIC ARTERY; HEPATOGRAPHY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LIVER WEIGHT; METASTASIS RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; VOLUMETRY;

EID: 84995792452     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2012.002     Document Type: Article

References (35)

1. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254-9.
2. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996;77:1254-62.
3. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18; discussion 318-21.
4. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13:51-64.
5. Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 2007;11:1057-77.
6. Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005;23:9073-8.
7. Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987;5:1836-40.
8. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987;107:459-65.
9. Kemeny N, Daly J. Prelimina ryresults of a randomized study of intrahepatic infusion versus systemic infusion of 5-f luoro-2'-deoxyuridine for metastatic colorectal carcinoma. Recent Results Cancer Res 1986;100:171-8.
10. Kemeny N, Conti JA, Cohen A, Campana P, Huang Y, Shi WJ, et al. Phase II study of hepatic arterial f loxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-95.
11. Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, Dematteo RP, et al. Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol 2011;29:884-9.
12. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.
13. Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009;27:3465-71.
14. Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994;220:50-2.
15. Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 2004;231:413-20.
16. Wicherts DA, de Haas RJ, van Kessel CS, Bisschops RH, Takahara T, van Hillegersberg R, et al. Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards. Eur J Radiol 2011;77:305-11.
17. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005;235:872-8.
18. Sahani DV, Krishnamurthy SK, Kalva S, Cusack J, Hahn PF, Santilli J, et al. Multidetector-row computed tomography angiography for planning intra-arterial chemotherapy pump placement in patients with colorectal metastases to the liver. J Comput Assist Tomogr 2004;28:478-84.
19. Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR. Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics 2009;29:1547-63.
20. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254:47-66.
21. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliaryspecific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009;29:1725-48.
22. Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 2011;31:1547-68.
23. Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol 2011;197:W256-9.
24. Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, et al. The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 2008;35:1323-9.
25. Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F, et al. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. AJR Am J Roentgenol 2008;191:1436-9.
26. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257:674-84.
27. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, et al. Diagnosis of colorectal hepatic metastases: comparison of contrastenhanced CT, contrast-enhanced US, superparamagnetic iron oxideenhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011;34:326-35.
28. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE. Gadoxetate disodiumenhanced magnetic resonance imaging versus contrast-enhanced 18F-f luorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol 2011;46:548-55.
29. Donati OF, Reiner CS, Hany TF, Fornaro J, von Schu Lthess GK, Marincek B, et al. 18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT. Nuklearmedizin 2010;49:106-14.
30. Oellerich M, Burdelski M, Ringe B, Lamesch P, Gubernatis G, Bunzendahl H, et al. Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet 1989;1:640-2.
31. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991;36:1197-203.
32. Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med 1979;90:185-7.
33. van der Vorst JR, van Dam RM, van Stiphout RS, van den Broek MA, Hollander IH, Kessels AG, et al. Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software. World J Surg 2010;34:2426-33.
34. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res 2009;39:107-16.
35. Dello SA, van Dam RM, Slangen JJ, van de Poll MC, Bemelmans MH, Greve JW, et al. Liver volumetry plug and play: do it yourself with ImageJ. World J Surg 2007;31:2215-21.